NADOLOL
Esophageal Varices With Bleeding
National Science and Technology Council, TaiwanSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Esophageal Varices With Bleeding cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Apsolol West China Hospital | Phase 4 | BBB |
Normal Human Serum Albumin King George's Medical University | Phase 4 | BB |
CARVEDILOL West China Hospital | Phase 4 | BB |
Phytonadione, (E)-(±)- Tanta University | Phase 4 | BB |
Midodrine Hospital Clinic of Barcelona | Phase 4 | BB |
View all 15 →
Same molecule, other indications
NADOLOL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →